Memphis Pharmaceuticals & Chemical Industries (EGX: MPCI)

MPCI Balance Sheet

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	519.86	519.86	143.53	83.83	52.6	46.76
Cash & Short-Term Investments	519.86	519.86	143.53	83.83	52.6	46.76
Cash Growth	262.20%	262.20%	71.22%	59.38%	12.48%	-3.01%
Accounts Receivable	338.14	338.14	335.75	78.66	27.92	43.27
Other Receivables	-	-	-	40.02	28.3	16.37
Receivables	338.14	338.14	335.75	208.19	140.35	134.14
Inventory	254.53	254.53	221.22	172.55	160.63	111.24
Prepaid Expenses	-	-	-	1.9	0.49	0.27
Other Current Assets	-	-	-	14.14	4.35	8.67
Total Current Assets	1,113	1,113	700.49	480.61	358.41	301.08
Property, Plant & Equipment	86.48	86.48	63.5	54.63	44.49	44.17
Long-Term Investments	6.49	6.49	6.49	6.49	6.49	6.49
Other Intangible Assets	8.83	8.83	12.46	16.1	19.73	23.37
Long-Term Deferred Tax Assets	2.72	2.72	2.72	2.47	2.47	2.32
Other Long-Term Assets	-	-	-	0	-	-
Total Assets	1,217	1,217	785.66	560.29	431.58	377.41
Accounts Payable	694.28	694.28	589.12	461.44	401.98	341.21
Accrued Expenses	13.89	13.89	12.34	10.15	9.34	13.74
Short-Term Debt	69.27	69.27	10.98	4.73	5.36	7.4
Current Unearned Revenue	0.09	0.09	0.09	0.09	-	0.09
Other Current Liabilities	178.43	178.43	64.27	45.68	50.6	76.07
Total Current Liabilities	955.97	955.97	676.8	522.08	467.28	438.52
Long-Term Debt	109.54	109.54	2.34	-	-	-
Long-Term Deferred Tax Liabilities	2.45	2.45	1.57	1.57	1.37	1.37
Other Long-Term Liabilities	-	-	-	-	1.11	16.39
Total Liabilities	1,068	1,068	680.7	523.65	469.77	456.28
Common Stock	56.25	56.25	56.25	56.25	56.25	56.25
Retained Earnings	89.34	89.34	45.61	-22.7	-97.52	-138.2
Comprensive Income & Other	3.49	3.49	3.09	3.09	3.09	3.09
Shareholders' Equity	149.08	149.08	104.95	36.64	-38.18	-78.86
Total Liabilities & Equity	1,217	1,217	785.66	560.29	431.58	377.41
Total Debt	178.82	178.82	13.32	4.73	5.36	7.4
Net Cash (Debt)	341.04	341.04	130.21	79.1	47.23	39.36
Net Cash Growth	161.92%	161.92%	64.62%	67.45%	20.02%	-15.55%
Net Cash Per Share	60.63	60.63	23.15	14.06	-	7.00
Filing Date Shares Outstanding	5.63	5.63	5.63	5.63	-	5.63
Total Common Shares Outstanding	5.63	5.63	5.63	5.63	-	5.63
Working Capital	156.56	156.56	23.7	-41.47	-108.87	-137.44
Book Value Per Share	26.50	26.50	18.66	6.51	-	-14.02
Tangible Book Value	140.25	140.25	92.49	20.55	-57.92	-102.23
Tangible Book Value Per Share	24.93	24.93	16.44	3.65	-	-18.17
Land	0.59	0.59	0.59	0.59	0.59	0.59
Buildings	93.19	93.19	60.56	60.56	59.6	59.36
Machinery	148.08	148.08	141.61	141.61	140.68	139.51
Construction In Progress	20.05	20.05	38.51	27.54	16.08	11.43

Source: S&P Capital IQ. Standard template. Financial Sources.